MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
PLX Protalix Biotherapeutics
- 1.760
- +0.020+1.15%
Close Dec 20 16:00 ET
- 1.760
- 0.0000.00%
Post 18:22 ET
129.60MMarket Cap-11.73P/E (TTM)
1.785High1.690Low344.36KVolume1.690Open1.740Pre Close601.48KTurnover0.63%Turnover Ratio19.56P/E (Static)73.63MShares1.90052wk High3.99P/B96.36MFloat Cap0.82152wk Low--Dividend TTM54.75MShs Float1037.500Historical High--Div YieldTTM5.46%Amplitude0.700Historical Low1.746Avg Price1Lot Size
About Protalix Biotherapeutics Company
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Company Profile
SymbolPLX
Company NameProtalix Biotherapeutics
Listing DateApr 9, 1996
Issue Price6.00
Founded1993
CEOMr. Dror Bashan
MarketAMEX
Employees208
Fiscal Year Ends12-31
Address2 University Plaza,Suite 100
CityHackensack
ProvinceNew Jersey
CountryUnited States of America
Zip Code07601
Websitehttp://www.protalix.com
Company Executives
- Name
- Position
- Salary
- Dror Bashan
- Director, President and Chief Executive Officer
- 2.68M
- Eyal Rubin
- Senior Vice President, Chief Financial Officer, Treasurer, Secretary and Principal Accounting Officer
- 1.03M
- Yaron Naos
- Senior Vice President, Operations
- 776.37K
- Dr. Eliot Richard Forster, M.B.A.,PhD
- Chairman of the Board
- 47.99K
- Dr. Aharon Schwartz,PhD
- Independent Director
- 79.91K
- Gwen A. Melincoff
- Independent Director
- 79.91K
- Dr. Pol F. Boudes,M.D.
- Independent Director
- 115.39K
- Dr. Shmuel Ben-Zvi, PhD
- Independent Director
- 74.71K
- Amos Bar Shalev
- Independent Director
- 79.91K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.